Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

PIPERACILLIN AND TAZOBACTAM

PIPERACILLIN SODIUM; TAZOBACTAM SODIUM

Standard Dose
EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview PIPERACILLIN AND TAZOBACTAM is listed in Drugs@FDA under application 217409 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient PIPERACILLIN SODIUM; TAZOBACTAM SODIUM Form and strength INJECTABLE;INJECTION - EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL Sponsor EUGIA PHARMA Submission history Latest submission status date: 2024-12-03 00:00:00.

Structured Monograph

Clinical summary

Approval overview PIPERACILLIN AND TAZOBACTAM is listed in Drugs@FDA under application 217409 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient PIPERACILLIN SODIUM; TAZOBACTAM SODIUM Form and strength INJECTABLE;INJECTION - EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL Sponsor EUGIA PHARMA Submission history Latest submission status date: 2024-12-03 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.